Experimental Two-Step radiation therapy tested in patients with no other options
NCT ID NCT05994157
Summary
This early-phase study tested a new two-step radioactive treatment for people with advanced non-Hodgkin lymphoma that had returned or stopped responding to standard treatments. The goal was to find safe doses and timing for this experimental therapy, which combines a targeting molecule with a radioactive drug. The trial was terminated after enrolling only one participant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Corewell Health-BAMF Health
Grand Rapids, Michigan, 49503, United States
-
East Carolina University Leo W. Jenkins Cancer Center
Greenville, North Carolina, 27834, United States
-
HonorHealth
Scottsdale, Arizona, 85258, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Stony Brook Cancer Center
Stony Brook, New York, 11794, United States
Conditions
Explore the condition pages connected to this study.